Complement factor D derived from epicardial adipose tissue participates in cardiomyocyte apoptosis after myocardial

Shuang Hao1, Jingchao Zhang1, Yu Pei1

  • 1Department of Cardiac Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.

Cellular Signalling
|November 9, 2022
PubMed

Insights

Epicardial adipose tissue (EAT) secretes complement factor D (CFD) after myocardial infarction (MI), promoting cardiomyocyte apoptosis via PARP-1 activation. Inhibiting CFD alleviates this damage, offering a potential therapeutic target for heart failure post-MI.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathophysiology

Background:

  • Acute myocardial infarction (MI) is a primary cause of congestive heart failure.
  • Understanding the underlying pathophysiological processes is crucial for developing interventions.

Purpose of the Study:

  • To analyze the pathophysiological mechanisms of acute MI.
  • To identify key therapeutic targets for MI-induced heart failure.

Main Methods:

  • Established a rat model of MI by ligating the left anterior descending branch.
  • Collected heart, epicardial adipose tissue (EAT), and subcutaneous adipose tissue (SAT).
  • Utilized H9c2 cells to investigate the role of complement factor D (CFD) in cardiomyocyte apoptosis.

Main Results:

  • MI rats exhibited myocardial apoptosis and increased EAT.
  • EAT-conditioned medium reduced H9c2 cell activity.
  • Elevated CFD in EAT promoted cardiomyocyte apoptosis via PARP-1 activation, which was reversed by CFD inhibition (CFD-IN1).

Conclusions:

  • Epicardial adipose tissue (EAT) mediates cardiomyocyte apoptosis following MI.
  • CFD secretion by EAT and subsequent PARP-1 activation are key mechanisms.
  • Inhibition of CFD presents a potential therapeutic strategy for MI.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23